Find similar content

Source channel @githubtrending · Post #15038 · Aug 8

#python#agent#agentic#agentic_ai#agents#agents_sdk#ai#ai_agents#aiagentframework#genai#genai_chatbot#llm#llms#multi_agent#multi_agent_systems#multi_agents#multi_agents_collaboration The Agent Development Kit (ADK) is an open-source Python toolkit that helps you easily build, test, and deploy smart AI agents, from simple helpers to complex multi-agent systems. It lets you write agent logic in Python, use many built-in or custom tools, and organize multiple agents to work together. You can deploy agents anywhere, including Google Cloud, and evaluate their performance with built-in tools. ADK supports flexible workflows and works with various AI models, not just Google’s. This means you get full control and flexibility to create powerful AI applications that fit your needs, speeding up development and making it easier to manage AI projects. https://github.com/google/adk-python

Hashtags

#python #agent #agentic #agentic_ai #agents #agents_sdk #ai #ai_agents #aiagentframework #genai #genai_chatbot #llm #llms #multi_agent #multi_agent_systems #multi_agents #multi_agents_collaboration

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment